ARKG

ARK Genomic Revolution Multi-Sector ETF

Up$31.54
+$1.09
(+3.58%)
As of 12:58:52 PM EDT | 6/17/19  |  Market Open

ARKG Trading Data

Open

$30.5

Low Price

$30.5

High Price

$31.55

Previous Last Price

$30.45

Bid Size

$31.53 X 1600

Ask Size

$31.56 X 500

ARKG Portfolio Data

AUM

$411,037,600

Shares

13,255

PE Ratio

28.06

Price / Book Ratio

4.48

Expense Ratio

0.75

Net Asset Value

$31.01

Volume

Volume

50,320

Avg. Volume (YDT)

144,558

Dollar Volume

$1,505,854

Weekly Avg. Volume

154,486

Monthly Avg. Volume

135,396

Quarterly Avg. Volume

159,419

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

ARKG Chart

ARKG Summary

Fund Family

Ark Funds

Tracks This Index

ARK Genomic Revolution Multi-Sector ETF

Inception Date

2014-11-04

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

ARKG Classification

Region (General)

Global

Region (Specific)

Sector

Multi-Sector

Equity Index

Leveraged Family

ARKG Holdings

Top 10 Holdings

ILLUMINA INC (ILMN)
11.94%
INVITAE CORP (NVTA)
9.16%
CRISPR THERAPEUTICS AG (CRSP)
6.7%
INTELLIA THERAPEUTICS INC (NTLA)
6.45%
EDITAS MEDICINE INC (EDIT)
5.83%
VERACYTE INC (VCYT)
5.26%
NANOSTRING TECHNOLOGIES INC (NSTG)
3.97%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
3.89%
BRISTOL-MYERS SQUIBB CO (BMY)
3.37%
CELLECTIS - ADR (CLLS)
3.32%

Total ARKG Holdings

Total Holdings: 35

ILLUMINA INC (ILMN)
11.94%
INVITAE CORP (NVTA)
9.16%
CRISPR THERAPEUTICS AG (CRSP)
6.7%
INTELLIA THERAPEUTICS INC (NTLA)
6.45%
EDITAS MEDICINE INC (EDIT)
5.83%
VERACYTE INC (VCYT)
5.26%
NANOSTRING TECHNOLOGIES INC (NSTG)
3.97%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
3.89%
BRISTOL-MYERS SQUIBB CO (BMY)
3.37%
CELLECTIS - ADR (CLLS)
3.32%
TELADOC HEALTH INC (TDOC)
3.21%
MEDIDATA SOLUTIONS INC (MDSO)
3.18%
INCYTE CORP (INCY)
2.56%
COMPUGEN LTD (CGEN)
2.53%
IONIS PHARMACEUTICALS INC (IONS)
2.47%
INOVIO PHARMACEUTICALS INC (INO)
2.4%
NVIDIA CORP (NVDA)
1.97%
REGENERON PHARMACEUTICALS (REGN)
1.74%
RUBIUS THERAPEUTICS INC (RUBY)
1.69%
CERUS CORP (CERS)
1.67%
GUARDANT HEALTH INC (GH)
1.66%
ARCTURUS THERAPEUTICS HOLDIN (ARCT UQ)
1.61%
CODEXIS INC (CDXS)
1.45%
BLUEBIRD BIO INC (BLUE)
1.42%
TWIST BIOSCIENCE CORP (TWST)
1.33%
SYROS PHARMACEUTICALS INC (SYRS)
1.22%
CAREDX INC (CDNA)
1.19%
CELLULAR BIOMEDICINE GROUP I (CBMG)
1.16%
APPLE INC (AAPL)
1.16%
SERES THERAPEUTICS INC (MCRB)
1.02%
FATE THERAPEUTICS INC (FATE)
0.8%
BELLICUM PHARMACEUTICALS INC (BLCM)
0.73%
PLURISTEM THERAPEUTICS INC (PSTI)
0.73%
ORGANOVO HOLDINGS INC (ONVO)
0.64%
ARK Genomic Revolution Multi-Sector ETF (ARKG)
0%

ARKG Technicals

Alpha

5.34

Beta

1.87

Leverage

Long

Standard Deviation

2.43

ARKG Dividends

Dividend Date

2018-12-27

Latest Dividend

0.27

Annual Dividend

0.27

Annual Dividend Rate

0.27

Annual Dividend Yield

0.87

ARKG Performance

YTD Return

31.24%

1 Year Return

4.08%

3 Year Return

80.5%

5 Year Return

0%

10 Year Return

51.49%

ARKG Related Articles